$2M granted for clinical trial of Rapamycin in Alzheimer's
UT Health San Antonio - 25-Aug-2020People are now willing to say that treating ageing might help ameliorate age-related diseases
Join the club for FREE to access the whole archive and other member benefits.
Robert R. Barker Distinguished University Professor of Neurology at UTHSCSA
Dr. Seshadri is a senior investigator of the Framingham Heart Study since 1998, leading the study’s clinical neurology and neurogenesis cores since 2005. She is the principal investigator on 8 NIH funded grants and is an investigator, subcontract principal investigator and consultant to 12 additional grants.
She has served on the Editorial Board for Neurology and Stroke, chaired a standing NIH Study Section (Neurology, Aging and Musculoskeletal Epidemiology) and has over 320 peer-reviewed publications (H-index 79, i10 index 209), including 57 in 2016.
Dr. Seshadri helped to establish the neurology phenotype working group within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
Visit website: https://www.uthscsa.edu/academics/medicine/profile/seshadri
See also: UT Health San Antonio - Public academic health science center in San Antonio, Texas.
Details last updated 01-Dec-2019
People are now willing to say that treating ageing might help ameliorate age-related diseases
Blood circulation in the brain didn't deteriorate even a bit for 15 months